In addition, although the present work focused on the contrast agent enhanced core of the tumors to ensure technical homogeneity, diffusion characteristics of non-enhancing tumor parenchyma and peritumoral edema may also encode IDH-related signatures. The gene discussed is IDH1; the disease is neoplasm.